Home›Companies›Biotech & Pharma›Sendero Biotechnology

Sendero Biotechnology, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 28, 2023·Suggest an edit

About Sendero Biotechnology

Sendero Biotechnology is a private company based in Rochester, Michigan, incorporated in 2021 in Delaware. It has reported $7,336,954 raised in one offering on Form D since April 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 15, 2023Apr 28, 2023$7,336,954fully sold2$3.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sendero Biotechnology's Form D filed Apr 28, 2023.

MC
Michael Cola
Executive officer and director
AB
JB
Joshua Barer
Director
GO

Sources

  1. SECSENDERO BIOTECHNOLOGY, INC. filing history